Apotheek Defever SRL
2.0 FTEThe score of Apotheek Defever shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +34 % Total assets +21 % Headcount (avg FTE) -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Defever's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Apr 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Apotheek Defever's financial analysis
- Solvency65.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Defever
Apotheek Defever's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0878.760.612
- VAT number
- BE0878760612
- Peppol
- Registered · 0208:0878760612 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Jan 2006
- Registered office
- 1770 Liedekerke
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Defever (SRL) has been based in Liedekerke since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 119,181 € and equity of €1.36m; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 65.5%, above the median of its sector (44.2%).
Companies similar to Apotheek Defever
Companies in the same business, of comparable size and area, outside its group.
- Apoteken Bosmans - Konings Retail sale of pharmaceutical products Antwerp · balance sheet €2.08m
- A.R.Pharma Retail sale of pharmaceutical products Charleroi · balance sheet €2.09m
- Pharmacie Crunenberg-Gillet Retail sale of pharmaceutical products Stavelot · balance sheet €2.07m
- Portpharma Retail sale of pharmaceutical products Bruges · balance sheet €2.04m
- Westlaanapotheek Retail sale of pharmaceutical products Roeselare · balance sheet €2.04m
- Cobra Apotheek Retail sale of pharmaceutical products Mol · balance sheet €2.02m
- Goessaert Retail sale of pharmaceutical products Zulte · balance sheet €2.02m
- Pharmaccueil Retail sale of pharmaceutical products Limbourg · balance sheet €2.00m
Frequently asked questions about Apotheek Defever
What is the revenue of Apotheek Defever?
Apotheek Defever files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Defever?
In Belgium, the VAT number is the company number prefixed with BE: BE0878760612 for Apotheek Defever, if the company is VAT-registered. Its company number (CBE) is 0878.760.612.
Where is the registered office of Apotheek Defever?
According to the CBE register, the registered office of Apotheek Defever is in 1770 Liedekerke.
What is the equity of Apotheek Defever?
At the close of the 2025 financial year, the equity of Apotheek Defever amounts to 1,362,488 €, a solvency of 65.5% of total assets.
How many people work at Apotheek Defever?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apotheek Defever?
The register lists 1 active mandates at Apotheek Defever. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Defever
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →